Middle East News Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Digest.

Press releases published on May 12, 2026

May 12, 2026

FL PR and Communications Engages with Sector Leaders at Türkiye - Belgium Business Forum Hosting Queen Mathilde

Indeterminate GlobeNewswire

May 12, 2026

NEVGOLD ANNOUNCES CLOSING OF UPSIZED $42M BROKERED PRIVATE PLACEMENT FINANCING

Indeterminate GlobeNewswire

May 12, 2026

Agios Submits sNDA to FDA for U.S. Accelerated Approval of Mitapivat in Sickle Cell Disease

Indeterminate GlobeNewswire

May 12, 2026

Cogent Biosciences Announces Multiple Presentations at the European Hematology Association (EHA) 2026 Congress

Indeterminate GlobeNewswire

May 12, 2026

Agios to Present New Data at EHA 2026 Reinforcing the Significant Therapeutic Impact of Mitapivat Across Multiple Rare Hemolytic Anemias

Indeterminate GlobeNewswire

May 12, 2026

Ajax Therapeutics Announces Oral Presentation of Clinical Results from AJX-101, a Phase I study of AJ1-11095, a First-in-Class Type II JAK2 Inhibitor, at the European Hematology Society (EHA) 2026 Congress

Indeterminate GlobeNewswire

May 12, 2026

Cellectis to Present Clinical Data on Lasme-cel and Eti-cel at EHA 2026 Annual Congress

Indeterminate GlobeNewswire

May 12, 2026

Cellectis présentera des données cliniques sur lasmé-cel et éti-cel au congrès annuel de l’EHA 2026

Indeterminate GlobeNewswire

May 12, 2026

Token Security Named to Rising in Cyber 2026 List of Top Cybersecurity Startups

Indeterminate GlobeNewswire

May 12, 2026

Globex Enters Option Agreement on its Ramp/Maude Lake Gold Property in Ontario

Indeterminate GlobeNewswire

May 12, 2026

Clearmind Medicine Reaches Important Clinical Milestone: 20 Participants Now Treated in Ongoing Phase I/IIa Trial of CMND-100 for Alcohol Use Disorder

Indeterminate GlobeNewswire

May 12, 2026

Orchestra BioMed Targeting BACKBEAT Trial Enrollment Completion By End of Q3 2026 and Data Presentation in Q2 2027

Indeterminate GlobeNewswire

May 12, 2026

Oncotelic Therapeutics Inc. (OTCQB: OTLC) Proprietary N2B System May Offer Key to Unlocking Next-Gen Therapies

Indeterminate GlobeNewswire

May 12, 2026

SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Advancing a Differentiated Next-Gen GLP-1 Platform

Indeterminate GlobeNewswire

May 12, 2026

CRML Set to Become the Market Leader for Hafnium Production and Supply Security Taking Away China's Current 75% Market Share

Indeterminate GlobeNewswire

May 12, 2026

TFSF Ventures commits to making AI agent deployment accessible to all

Indeterminate EIN Presswire

May 12, 2026

Rhythm Pharmaceuticals Announces New Data Presentations at the 2026 European Congress of Endocrinology

Indeterminate GlobeNewswire

May 12, 2026

Cerevance Completes Enrollment in Pivotal Phase 3 Parkinson’s Disease Trial and Closes Oversubscribed $20 Million Series C to Extend Runway into 2027

Indeterminate GlobeNewswire

May 12, 2026

Lyell Immunopharma Announces Participation in May Investor Conferences

Indeterminate GlobeNewswire

May 12, 2026

Trident Resources Commences Regional Structural Analysis of its La Ronge Gold Belt Properties in Saskatchewan with SRK Consulting

Indeterminate GlobeNewswire